fludarabine has been researched along with Lymphatic Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gorman, C; Hudson, E; Lester, JF; Maughan, TS; Poynton, CH; Westmoreland, D | 1 |
| Holmes, NE; Kelman, A; Korman, TM; Opat, S | 1 |
| Chen, LY; Collins, D; Coupland, R; Fung, AT; Gerrie, AS; Maberley, D; Moloney, G; Rossman, D; White, V; Wong, PC | 1 |
| Browning, M; Faderl, S; Ferrajoli, A; Kantarjian, H; Khouri, I; Lerner, S; O'Brien, S; Tam, CS; Tsimberidou, AM; Wierda, WG | 1 |
| Lärfars, G; Samuelsson, J; Udén-Blohmé, AM | 1 |
5 other study(ies) available for fludarabine and Lymphatic Diseases
| Article | Year |
|---|---|
Severe prolonged immunosuppression following fludarabine and rituximab combination therapy.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Drug Therapy, Combination; Female; Humans; Immune Tolerance; Lymphatic Diseases; Middle Aged; Rituximab; Vidarabine | 2008 |
Refractory Bartonella quintana bacillary angiomatosis following chemotherapy for chronic lymphocytic leukaemia.
Topics: Aged; Angiomatosis, Bacillary; Anti-Bacterial Agents; Antineoplastic Agents; Bacteriological Techniques; Bartonella quintana; Drug Therapy; Female; Humans; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphatic Diseases; Microscopy; Osteomyelitis; Treatment Failure; Vidarabine | 2011 |
IgG4-related disease with hypergammaglobulinemic hyperviscosity and retinopathy.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Drug Therapy, Combination; Humans; Hypergammaglobulinemia; Immunoglobulin G; Immunologic Factors; Lacrimal Apparatus; Lymph Nodes; Lymphatic Diseases; Male; Retinal Degeneration; Rituximab; Vasculitis; Vidarabine | 2013 |
The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Agents; Drug Resistance, Neoplasm; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphatic Diseases; Male; Middle Aged; Models, Biological; Rituximab; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2007 |
Fludarabine, as well as 2-chlorodeoxyadenosine, can induce eosinophilia during treatment of lymphoid malignancies.
Topics: Aged; Antineoplastic Agents; Cladribine; Eosinophilia; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphatic Diseases; Lymphoma, Follicular; Male; Middle Aged; Retrospective Studies; Vidarabine | 1996 |